Skip to the page

Data / Form D filings / Orphion Therapeutics, Inc.

Orphion Therapeutics, Inc.: Form D filing

Orphion Therapeutics, Inc., a pharmaceuticals company in Great Neck, NY, filed a Form D with the SEC in 2020. The latest, on November 17, 2020, reports $5.3 million sold of a $16.3 million offering to 4 investors.

Find out what Orphion Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
57 MEADOW WOODS ROAD, Great Neck, NY, 11020
Phone
(917) 951-5659
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1832539

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 17, 2020New notice$16,332,500$5,332,500$11,000,0004Nov 10, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason SlakterExecutive Officer, Director
Michael MashaalDirector
Nickolay VoroninDirector

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of Nov 16, 2020 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Orphion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.